Viewing nowCombinationEmpagliflozin/Metformin Hydrochloride 12.5/1000 mg Tablet
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.

MFDS item code 202302570 · Approved 2023.08.30 · Insurance code 698504920
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is particularly effective for patients whose blood sugar is not well-controlled, and caution is required for patients with cardiovascular disease regarding the occurrence of cardiovascular events. Therefore, this medication helps to improve blood sugar management and prevent complications related to diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in that case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication may cause a rare but serious side effect called lactic acidosis, so caution is warranted. When used in conjunction with other diabetes medications, hypoglycemia may occur, so caution is necessary. It should not be used in patients with significantly impaired kidney function, acute kidney issues, serious infections, heart failure, or other serious conditions. It is safe to avoid this medication in pregnant or breastfeeding women. Kidney function should be regularly monitored before and during treatment to assess condition. Caution is advised in situations of dehydration or where there is a risk of dehydration. This medication may increase the risk of urinary tract infections and genital infections, so consult a doctor immediately if symptoms of infection occur. In some patients, urination may increase, which should be noted. Long-term use may decrease vitamin B12 levels, so regular blood tests are necessary. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided during use. This medication should be temporarily discontinued before and after surgery or tests using radiocontrast agents, and resumed only after confirming normal kidney function. Elderly patients are at higher risk for reduced kidney function, so dose adjustments and periodic monitoring are required. Any symptoms of hypoglycemia, lactic acidosis, or ketoacidosis during treatment should be reported to healthcare professionals immediately. This medication is not used in children as safety and efficacy have not been verified.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be kept in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.
A double-sided, convex, oval film-coated tablet with a dark brownish purplish color.
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.